By IDSE News Staff
Doxycycline taken after sex does not prevent the sexually transmitted infections (STIs) chlamydia or gonorrhea among cisgender women, according to research presented at CROI 2023, in Seattle. 
The dPEP Kenya trial conducted in Kisumu, Kenya, evaluated the effectiveness of doxycycline post-exposure prophylaxis (PEP) to prevent bacterial STIs in cisgender women after multiple studies showed a high level of STI protection with doxycycline use among cisgender men and